These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 21386735

  • 21. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
    Chen L, Altmann A, Mier W, Eskerski H, Leotta K, Guo L, Zhu R, Haberkorn U.
    J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
    [Abstract] [Full Text] [Related]

  • 22. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC.
    Clin Cancer Res; 2005 Feb 15; 11(4):1483-9. PubMed ID: 15746050
    [Abstract] [Full Text] [Related]

  • 23. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
    Li W, Tan J, Wang P, Li N, Li C.
    Mol Cell Biochem; 2015 Jan 15; 399(1-2):279-89. PubMed ID: 25410753
    [Abstract] [Full Text] [Related]

  • 24. Study on molecular imaging and radionuclide therapy of human nasopharyngeal carcinoma cells transfected with baculovirus-mediated sodium/iodine symporter gene.
    Wang J, Liu S, Wang J, Zhang Y, Li B, Cai C, Wang S.
    Int J Oncol; 2013 Jul 15; 43(1):177-84. PubMed ID: 23670584
    [Abstract] [Full Text] [Related]

  • 25. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.
    Zhang M, Guo R, Shi S, Miao Y, Zhang Y, Li B.
    PLoS One; 2014 Jul 15; 9(3):e92326. PubMed ID: 24647588
    [Abstract] [Full Text] [Related]

  • 26. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Romijn JA, van der Heide D.
    Exp Clin Endocrinol Diabetes; 2001 Jul 15; 109(1):52-5. PubMed ID: 11573141
    [Abstract] [Full Text] [Related]

  • 27. The feasibility of using a baculovirus vector to deliver the sodium-iodide symporter gene as a reporter.
    Zhou X, Li B, Wang J, Yin H, Zhang Y.
    Nucl Med Biol; 2010 Apr 15; 37(3):299-308. PubMed ID: 20346869
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon.
    Pan Y, Zhao Q, Fang L, Luo R, Chen H, Xiao S.
    J Gene Med; 2009 Nov 15; 11(11):1030-8. PubMed ID: 19757479
    [Abstract] [Full Text] [Related]

  • 30. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter.
    Lin X, Fischer AH, Ryu KY, Cho JY, Sferra TJ, Kloos RT, Mazzaferri EL, Jhiang SM.
    J Clin Endocrinol Metab; 2004 May 01; 89(5):2344-50. PubMed ID: 15126562
    [Abstract] [Full Text] [Related]

  • 34. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E, Unfer R, Vahanian N, Link C.
    Gene Ther; 2006 Jul 01; 13(13):1052-6. PubMed ID: 16525480
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Approaches to gene therapy with sodium/iodide symporter.
    Spitzweg C, Morris JC.
    Exp Clin Endocrinol Diabetes; 2001 Jul 01; 109(1):56-9. PubMed ID: 11573142
    [Abstract] [Full Text] [Related]

  • 37. Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.
    Shen DH, Marsee DK, Schaap J, Yang W, Cho JY, Hinkle G, Nagaraja HN, Kloos RT, Barth RF, Jhiang SM.
    Gene Ther; 2004 Jan 01; 11(2):161-9. PubMed ID: 14712300
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.